Dolan, Brian P <br/><br/>
Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Feb 2006 
 - 1447-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.176.3.1447  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigen Presentation--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--administration & dosage<br/>Cell Communication--immunology<br/>Cells, Cultured<br/>Dendritic Cells--immunology<br/>Epitopes, T-Lymphocyte--immunology<br/>Female<br/>Histocompatibility Antigens Class I--immunology<br/>Histocompatibility Antigens Class II--administration & dosage<br/>Lymphocyte Activation--immunology<br/>Lymphoma, B-Cell--immunology<br/>Male<br/>Melanoma, Experimental--immunology<br/>Mice<br/>Mice, Inbred A<br/>Mice, Inbred BALB C<br/>Mice, Inbred C3H<br/>Mice, Transgenic<br/>Necrosis<br/>Tumor Cells, Cultured